http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2734709-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6888a41922a142c836e77ac9453fc21 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate | 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00409e4b015be61ad988cfcb7dd932de |
| publicationDate | 2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2734709-C1 |
| titleOfInvention | Method for preventing placenta-associated complications in pregnant women with combined forms of thrombophilia |
| abstract | FIELD: medicine.SUBSTANCE: present invention relates to a method of preventing placenta-associated complications in pregnant women with combined thrombophilia. Prevention of placenta-associated complications in pregnant women with combined thrombophilia is ensured by prescribing low-molecular heparins from early pregnancy to the moment of delivery by subcutaneous administration of the preparation.EFFECT: technical result is reducing the risk of placenta-associated complications in women with a combination of genetic and acquired form of thrombophilia.1 cl, 2 ex |
| priorityDate | 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.